NCT03145324

Brief Summary

To collect the immunisation history of participants enrolled in a previous vaccine study (REC 09/H0604/107) in order to assess the influence of genetic variation on the level of immunity to routine immunisations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
166

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2013

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2013

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

October 16, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2014

Completed
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2016

Completed
7 months until next milestone

First Posted

Study publicly available on registry

May 9, 2017

Completed
Last Updated

October 5, 2021

Status Verified

May 1, 2017

Enrollment Period

1 year

First QC Date

October 16, 2013

Last Update Submit

September 27, 2021

Conditions

Immunization; Infection

Outcome Measures

Primary Outcomes (1)

  • The primary endpoint will be the completion of the collection of vaccination histories from consented participants.

    1 year

Interventions

Collection of vaccine historiesOTHER

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants enrolled in a previous vaccine study (REC 09/H0604/107)

You may not qualify if:

  • Individuals who do not have explicit consent for samples taken in the original vaccine study (09/H0604/107) to be stored for future research.
  • Individuals who have not been consented into this study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre for Clinical Vaccinology & Tropical Medicine (CCVTM)

Oxford, Oxfordshire, OX1 4LE, United Kingdom

Location

Related Links

MeSH Terms

Conditions

Infections

Study Officials

  • Andrew Pollard Pollard, PhD

    University of Oxford

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 16, 2013

First Posted

May 9, 2017

Study Start

October 1, 2013

Primary Completion

October 1, 2014

Study Completion

October 1, 2016

Last Updated

October 5, 2021

Record last verified: 2017-05

Locations

GB(1)